Latest Feature

Gov. Deval Patrick's life sciences legacy

MassDevice.com looks at the life sciences legacy of former Massachusetts Gov. Deval Patrick.

Weight loss: ReShape Medical's Duo balloon system looks to curb obesity

A Q&A with ReShape Medical CEO Richard Thompson on the company's cash pay procedure and how it can make a dent in obese patients.

DeviceTalks podcast: Masimo CEO Kiani

An interview with medtech entrepreneur Joe Kiani, CEO of Masimo Corp. and the founder of the Patient Safety Movement Foundation, recorded at DeviceTalks West Nov. 19, 2014.

HeartFlow wins FDA OK for non-invasive FFR system

The FDA grants de novo clearance to HeartFlow's novel system for non-invasive measurement of fractional flow reserve, which CEO Dr. John Stevens calls "the gold standard" for diagnosing and treating coronary disease.

DeviceTalks podcast: B. Braun Medical CEO Caroll Neubauer on device tax, Obamaca

Caroll Neubauer, the CEO of B. Braun Medical, sits down for a wide-ranging interview on the hottest topics facing the medical device industry.

Latest Jobs

Knowledge Library

In today’s dynamic environment, there is a need like never before for clinical data. In addition to IDE’s, companies are finding themselves doing clinical
Subscribe to the MassDevice
Newsletter
Enter your email:

Need Medtech news in a minute? We Deliver!


MassDevice +3,+5 and +7 newsletters get you caught up on all the mission critical news you need in med tech. Sign up today for our free newsletter.

New Siemens healthcare unit to start in May

March 6, 2015 by MassDevice

Siemens is slated to launch its new healthcare business as soon as May, according to a pair of unnamed sources.

New Siemens healthcare unit to start in May

(Reuters) — Siemens (NYSE:SI) will house its German healthcare operations in a standalone unit in the form of a GmbH legal entity May 1, 2 sources with knowledge of the matter said.

San Francisco hospital begins rare 6-way kidney transplant chain

March 6, 2015 by MassDevice

Surgeons in San Francisco begin a 6-way kidney transplant chain involving 12 patients that began with a single altruistic donor.

San Francisco hospital begins rare 6-way kidney transplant chain

(Reuters) — Doctors at a San Francisco hospital began an unusual series of kidney transplants yesterday with 6 living donors providing organs to 6 patients in a chain that began with a woman described as an altruistic donor unrelated to any of the recipients.

Sunshine Heart stops trial enrollment after patient deaths

March 6, 2015 by Brad Perriello

Shares of Sunshine Heart plunge after the company reveals a halt in U.S. clinical trial enrollment for its C-Pulse heart failure device.

Sunshine Heart stops trial enrollment after patient deaths

Tandem Diabetes plans $60m offering | Medtech funding for the week of March 2, 2015

March 6, 2015 by MassDevice

Here's a look at some of the top legal news stories for medical device companies this week: Diabetes: Tandem plans $60m offering; OrthoSensor pulls in $17m funding round; EndoChoice raises $57m for Fuse endoscope; InspireMD looks to raise $14m for CGuard stent launch

Diabetes: Tandem plans $60m offering

March 2, 2015 by Mark Hollmer

Widow files wrongful death suit over superbug infection

March 6, 2015 by MassDevice

The widow of a patient who died after being infected with E. coli by an Olympus endoscope is suing the hospital and the company for wrongful death.

Widow files wrongful death suit over superbug infection

GI Dynamics plunges 50% after FDA halts trial

March 6, 2015 by Brad Perriello

Shares of GI Dynamics lose 50% of their value after the company reveals that the FDA halted enrollment a clinical trial of its EndoBarrier weight loss device.

GI Dynamics plunges 50% after FDA halts trial

Diabetes: Tandem closes $60m offering

March 6, 2015 by Val Kennedy

Tandem Diabetes Care closes on a public offering valued at roughly $60 million.

Tandem Diabetes closes $60m offering

Tandem Diabetes Care (NSDQ:TNDM) this week said it closed on a previously announced public offering valued at around $60 million.

Win some, lose some: J&J loses 1st Abbrevo case, holds on to bellwether win

March 6, 2015 by Brad Perriello

A California state jury hits Johnson & Johnson with a $5.7 million verdict in the 1st trial involving its Abbrevo pelvic mesh, and a federal appeals court upholds its win in the 1st bellwether case against its Ethicon subsidiary.

Win some, lose some: J&J loses 1st Abbrevo case, holds on to bellwether win